Microvessel Density and Mammaglobin A Expression as Prognostic Markers in Molecular Types of Breast Cancer

被引:0
|
作者
Jitariu, Adriana Andreea [1 ]
Ceausu, Amalia Raluca [1 ]
Meche, Adriana [2 ]
Nica, Cristian [3 ]
Burlea, Amelia [2 ]
Raica, Marius [1 ]
机构
[1] Victor Babes Univ Med & Pharm, Dept Microscop Morphol, Histol & Angiogenesis Res Ctr, 2 Eftimie Murgu Sq, Timisoara 300041, Romania
[2] Cty Clin Hosp, Dept Pathol, 2-4 Andreny Karoly Str, Arad 310037, Romania
[3] Pius Brinzeu Emergency Cty Hosp, Dept Gen Surg, 156 Liviu Rebreanu Blvd, Timisoara 300723, Romania
来源
REVISTA DE CHIMIE | 2019年 / 70卷 / 07期
关键词
breast cancer; angiogenesis; microvessel density; mammaglobin A; prognosis; TUMOR ANGIOGENESIS; IMMUNOHISTOCHEMICAL EXPRESSION; CARCINOMA; PROLIFERATION; METASTASIS; BLOOD;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Increased microvessel density (MVD) values in breast cancer correlate with tumor growth and progression while mammaglobin (MGB) expression in tumor cells is associated with a favorable prognosis, We aim to evaluate and correlate MVD values with MGB expression in molecular types of breast cancer specimens and to determine their utility as prognostic biological markers. A number of 52 breast cancer specimens were included in the study. Specimens were processed for routine histopathological diagnosis followed by the molecular classification by means of estrogen (ER), progesterone (PR) and HER2 immunohistochemical reactions. After performing immunohistochemistry for CD34 and MGB, MVD evaluation was made using the "hot spot" method for each case and MGB was scored between 0 (negative) and +3 (strong positive) depending on the intensity and distribution of the staining. MGB expression in tumor cells and MVD mean values were extremely variable. The greatest MVD mean values were obtained in luminal B followed by HER2, luminal A and triple negative breast cancer (TNBC) (95.33, 69, 62, and 40, respectively). MGB expression in the tumor cells generally ranged from mild to weak and was strong only in a few invasive ductal carcinoma cases, In cases with TNBCs the expression of MGB in tumor cells was weak and focal or negative, This variability was noticed between the molecular types of breast cancers and even within the same molecular type. In a restricted number of cases, MGB positive tumors were associated with low MVD values while the negative cases were characterized by increased MVD mean values. The variable results we obtained regarding the correlation between MVD and MGB in breast cancer specimens may indicate a rather restricted use of MVD/MGB in estimating breast cancer patients' prognosis.
引用
收藏
页码:2671 / 2676
页数:6
相关论文
共 50 条
  • [1] Lymphatic microvessel density and mast cells in molecular types of breast cancer
    Gaje, P.
    Cimpean, A. M.
    Raica, M.
    Ribatti, D.
    EJC SUPPLEMENTS, 2010, 8 (05): : 188 - 188
  • [2] Lymphatic Microvessel Density, VEGF-C, and VEGFR-3 Expression in Different Molecular Types of Breast Cancer
    Raica, Marius
    Cimpean, Anca Maria
    Ceausu, Raluca
    Ribatti, Domenico
    ANTICANCER RESEARCH, 2011, 31 (05) : 1757 - 1764
  • [3] Molecular prognostic markers in breast cancer
    Rajvir Dahiya
    Guoren Deng
    Breast Cancer Research and Treatment, 1998, 52 : 185 - 200
  • [4] Macrophage infiltration and its prognostic implications in breast cancer: The relationship with VEGF expression and microvessel density
    Tsutsui, S
    Yasuda, K
    Suzuki, K
    Tahara, K
    Higashi, H
    Era, S
    ONCOLOGY REPORTS, 2005, 14 (02) : 425 - 431
  • [5] Molecular prognostic markers in breast cancer
    Dahiya, R
    Deng, GR
    BREAST CANCER RESEARCH AND TREATMENT, 1998, 52 (1-3) : 185 - 200
  • [6] Microvessel density in breast cancer: the impact of field area on prognostic informativeness
    Kraby, Maria Ryssdal
    Opdahl, Signe
    Russnes, Hege Giercksky
    Bofin, Anna M.
    JOURNAL OF CLINICAL PATHOLOGY, 2019, 72 (04) : 304 - 310
  • [7] Subclassification of the molecular types of breast cancer based on the expression of immunohistochemical markers and evolution
    Reigosa, Aldo
    Hardisson, David
    Sanz, Francisco
    Caleiras, Eduardo
    Saldivia, Felipe
    Fernandez, Angel
    INVESTIGACION CLINICA, 2016, 57 (02): : 187 - 216
  • [8] Prognostic molecular markers in early breast cancer
    Esteva, FJ
    Hortobagyi, GN
    BREAST CANCER RESEARCH, 2004, 6 (03) : 109 - 118
  • [9] Prognostic molecular markers in early breast cancer
    Francisco J Esteva
    Gabriel N Hortobagyi
    Breast Cancer Research, 6
  • [10] Correlation between expression of molecular markers and their prognostic value for patients with breast cancer
    Shapochka, D.
    Shapochka, T.
    Zaletok, S.
    Gnidyuk, M.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S323 - S324